Genmab's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Genmab is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is €0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	kr 4.09B	kr 3.16B	kr 2.12B
Gross Profit	-	-	-	-	-
EBIT	-	-	kr 3.28B	kr 2.69B	kr 616.00M
EBITDA	-	-	kr 3.28B	kr 2.69B	kr 616.00M
Net Income Common Stockholders	-	-	kr 2.58B	kr 1.89B	kr 465.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	kr 28.14B	kr 22.32B	kr 23.79B	kr 21.61B	kr 19.99B
Total Assets	kr 35.29B	kr 30.28B	kr 30.69B	kr 27.48B	kr 24.91B
Total Debt	kr 770.00M	kr 597.00M	kr 629.00M	kr 634.00M	kr 416.00M
Net Debt	kr -27.36B	kr -21.73B	kr -23.16B	kr -20.98B	kr -19.57B
Total Liabilities	kr 3.68B	kr 2.84B	kr 4.03B	kr 2.99B	kr 2.19B
Stockholders Equity	kr 31.61B	kr 27.44B	kr 26.66B	kr 24.48B	kr 22.72B
Cash Flow	-
Free Cash Flow	-	-	kr 1.89B	kr 891.00M	kr 530.00M
Operating Cash Flow	-	-	kr 1.97B	kr 959.00M	kr 587.00M
Investing Cash Flow	-	-	kr -1.38B	kr -576.00M	kr -667.00M
Financing Cash Flow	-	-	kr -642.00M	kr -214.00M	kr -64.00M

Currency in DKK

Genmab Earnings and Revenue History

Income Statement >

Genmab Debt to Assets

Balance Sheet >

Genmab Cash Flow

Cash Flow >

Genmab Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing